# Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain

> **NCT00020839** · PHASE3 · TERMINATED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 23 (actual)

## Conditions studied

- Melanoma (Skin)
- Metastatic Cancer

## Interventions

- **DRUG:** temozolomide
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00020839
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-04
- **Primary completion:** 2003-05
- **Final completion:** —
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** low accrual
- **Last updated:** 2012-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00020839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00020839, "Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00020839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*